These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34926285)

  • 1. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
    Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
    Front Oncol; 2021; 11():776997. PubMed ID: 34926285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer.
    Fu J; Du F; Tian T; Huang H; Zhang L; Li D; Liu Y; Zhang D; Gao L; Zheng T; Liu Y; Zhao Y
    BMC Cancer; 2023 Jul; 23(1):620. PubMed ID: 37400788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer.
    Wang L; Chang N; Wu L; Li J; Zhang L; Chen Y; Zhou Z; Hao J; Wang Q; Jiao S
    Mol Clin Oncol; 2021 Dec; 15(6):257. PubMed ID: 34712487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer.
    Li X; Xiong Z; Xie M; Huang Q; Jin L; Yin S; Chen S; Lan P; Lian L
    J Gastrointest Oncol; 2021 Aug; 12(4):1470-1481. PubMed ID: 34532103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nomogram based on collagen signature for predicting the immunoscore in colorectal cancer.
    Jiang W; Yu X; Dong X; Long C; Chen D; Cheng J; Yan B; Xu S; Lin Z; Chen G; Zhuo S; Yan J
    Front Immunol; 2023; 14():1269700. PubMed ID: 37781377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients.
    Wang R; Dai W; Gong J; Huang M; Hu T; Li H; Lin K; Tan C; Hu H; Tong T; Cai G
    J Hematol Oncol; 2022 Jan; 15(1):11. PubMed ID: 35073937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic nomograms integrating preoperative serum lipid derivative and systemic inflammatory marker of patients with non-metastatic colorectal cancer undergoing curative resection.
    Huang D; Zheng S; Huang F; Chen J; Zhang Y; Chen Y; Li B
    Front Oncol; 2023; 13():1100820. PubMed ID: 36969019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer.
    Wang D; Yang Y; Jin L; Wang J; Zhao X; Wu G; Zhang J; Kou T; Yao H; Zhang Z
    J Cancer; 2019; 10(19):4552-4563. PubMed ID: 31528219
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Significance of and Predictive Risk Factors for the Postoperative Elevation of Carcinoembryonic Antigen in Patients With Non-Metastatic Colorectal Cancer.
    Zhou S; Sheng N; Ren J; He Q; Zhang Y; Gong J; Wang Z
    Front Oncol; 2021; 11():741309. PubMed ID: 34692522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer.
    Qu J; Jiang Y; Liu H; Deng H; Yu J; Qi X; Ge W; Li G
    Transl Oncol; 2017 Apr; 10(2):121-131. PubMed ID: 28126685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Prognostic Model and Practical Nomogram for Predicting the Outcomes of Colorectal Cancer: Based on Tumor Biomarkers and Log Odds of Positive Lymph Node Scheme.
    Zhu J; Hao J; Ma Q; Shi T; Wang S; Yan J; Chen R; Xu D; Jiang Y; Zhang J; Li J
    Front Oncol; 2021; 11():661040. PubMed ID: 33937076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery.
    Liu YH; Meng R; Zhu B; Zhan QQ; Yang X; Ding GY; Jia CL; Liu QY; Xu WG
    Pathol Oncol Res; 2023; 29():1610897. PubMed ID: 37334172
    [No Abstract]   [Full Text] [Related]  

  • 13. [Application of preoperative serum CYFRA 21-1 level in the prognosis of colorectal cancer].
    Hu WQ; Cong H; Fang RH; Yuan WT; Mao CY; Wang JR; Wang Y; Shi XY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1613-1619. PubMed ID: 37859379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
    Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
    Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the prognostic value of CD3 and CD8 cell densities analogous to the Immunoscore® by stage and location of colorectal cancer: an independent patient cohort study.
    Alwers E; Kather JN; Kloor M; Brobeil A; Tagscherer KE; Roth W; Echle A; Amitay EL; Chang-Claude J; Brenner H; Hoffmeister M
    J Pathol Clin Res; 2023 Mar; 9(2):129-136. PubMed ID: 36424650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival nomograms for stage III colorectal cancer.
    Li C; Pei Q; Zhu H; Tan F; Zhou Z; Zhou Y; Li Y; Pei H
    Medicine (Baltimore); 2018 Dec; 97(49):e13239. PubMed ID: 30544384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for predicting survival in stage I non-small cell lung cancer patients: nomogram based on macrophage immunoscore, TNM stage and lymphocyte-to-monocyte ratio.
    Gao J; Ren Y; Guo H; Mao R; Xie H; Su H; She Y; Deng J; Yang M; Han B; Zhang Y; Li J; Xie D; Chen C
    Ann Transl Med; 2020 Apr; 8(7):470. PubMed ID: 32395514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.
    Sinicrope FA; Shi Q; Hermitte F; Zemla TJ; Mlecnik B; Benson AB; Gill S; Goldberg RM; Kahlenberg MS; Nair SG; Shields AF; Smyrk TC; Galon J; Alberts SR
    JNCI Cancer Spectr; 2020 Jun; 4(3):pkaa023. PubMed ID: 32455336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
    Liu SX; Zhang L; Shi YK; Han XH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
    [No Abstract]   [Full Text] [Related]  

  • 20. Combining Immunoscore with Clinicopathologic Features in Cholangiocarcinoma: An Influential Prognostic Nomogram.
    Wu ZY; Shen W; Yue JQ; Yao WY; Liu SL; Jin YP; Dong P; Ma F; Wu XS; Gong W
    Onco Targets Ther; 2020; 13():11359-11376. PubMed ID: 33192071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.